Epidemiologic, virologic, and histologic data of 46 chronically HCV-infected patients
| Parameter . | Without MC . | With MC . |
|---|---|---|
| No. of patients | 26 | 20 |
| Age, y* | 56 ± 15 | 60 ± 14 |
| Sex (M/F) | 18/8 | 6/14† |
| HCV RNA positives, no. (%) | 26 (100) | 20 (100) |
| HCV genotypes, no. (%) | ||
| 1 | 13 (50) | 8 (40) |
| 2 | 11 (42) | 10 (50) |
| 3 | 2 (8) | 2 (10) |
| Liver histology, no. (%) | ||
| Chronic active hepatitis | 24 (92) | 18 (90) |
| Cirrhosis | 2 (8) | 2 (10) |
| Source of infection, no. (%) | ||
| Blood/blood product transfusions | 3 (12) | 2 (10) |
| Unknown | 23 (88) | 18 (90) |
| Durations of infection, y* | 28 ± 17 | 26 ± 12 |
| Parameter . | Without MC . | With MC . |
|---|---|---|
| No. of patients | 26 | 20 |
| Age, y* | 56 ± 15 | 60 ± 14 |
| Sex (M/F) | 18/8 | 6/14† |
| HCV RNA positives, no. (%) | 26 (100) | 20 (100) |
| HCV genotypes, no. (%) | ||
| 1 | 13 (50) | 8 (40) |
| 2 | 11 (42) | 10 (50) |
| 3 | 2 (8) | 2 (10) |
| Liver histology, no. (%) | ||
| Chronic active hepatitis | 24 (92) | 18 (90) |
| Cirrhosis | 2 (8) | 2 (10) |
| Source of infection, no. (%) | ||
| Blood/blood product transfusions | 3 (12) | 2 (10) |
| Unknown | 23 (88) | 18 (90) |
| Durations of infection, y* | 28 ± 17 | 26 ± 12 |